These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 11799842)
1. Studies on calcium antagonist activities of 2-ethyl-3-carbmethoxy-4-aryl- 5-oxo-6,6-dimethyl-1,4,5,6,7,8-hexahydroquinoline derivatives. Simşek R; Safak C; Erol K; Sirmagül B Arzneimittelforschung; 2001; 51(12):959-63. PubMed ID: 11799842 [TBL] [Abstract][Full Text] [Related]
2. Studies on 3-diethylaminocarbonyl-1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium channel antagonistic activities in vitro. Kismetli E; Safak C; Erol K; Sirmagül B; Linden A Arzneimittelforschung; 2004; 54(7):371-5. PubMed ID: 15344840 [TBL] [Abstract][Full Text] [Related]
3. Studies on calcium modulatory activities of 2,6,6-trimethyl-3-acetyl-4-aryl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives. Altaş Y; Safak C; Batu OS; Erol K Arzneimittelforschung; 1999 Oct; 49(10):824-9. PubMed ID: 10554659 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, evaluation of the calcium antagonistic activity and biotransformation of hexahydroquinoline and furoquinoline derivatives. Simşek R; Safak C; Erol K; Ataman S; Ulgen M; Linden A Arzneimittelforschung; 2003; 53(3):159-66. PubMed ID: 12705170 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, enantioseparation and pharmacological activity of 4-aryl-7,7-dimethyl-5-oxo-1,2,3,4,5,6,7,8-octahydroquinazoline-2-thiones. Yarim M; Saraç S; Ertan M; Kiliç FS; Erol K Arzneimittelforschung; 2002; 52(1):27-33. PubMed ID: 11838271 [TBL] [Abstract][Full Text] [Related]
6. Studies on the synthesis and biological activitiy of 6-ethyl-4-aryl-5-methoxycarbonyl-3,4-dihydropyrimidin-2(1H)-ones. Saraç S; Ciftçi M; Zorkun IS; Tunç O; Erol K Arzneimittelforschung; 2007; 57(3):137-42. PubMed ID: 17469647 [TBL] [Abstract][Full Text] [Related]
7. Studies on condensed 1,4-dihydropyridine derivatives and their calcium modulatory activities. Aydin F; Safak C; Simşek R; Erol K; Ulgen M; Linden A Pharmazie; 2006 Aug; 61(8):655-9. PubMed ID: 16964703 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro calcium antagonist activity of 4-aryl-7,7-dimethyl/1,7,7-trimethyl-1,2,3,4,5,6,7,8-octahydroquinazoline-2,5-dione derivatives. Yarim M; Saraç S; Kiliç FS; Erol K Farmaco; 2003 Jan; 58(1):17-24. PubMed ID: 12595033 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, structural elucidation and pharmacological properties of some 5-acetyl-3,4-dihydro-6-methyl-4-(substituted phenyl)-2(1H) -pyrimidinones. Yarim M; Sarac S; Ertan M; Batu OS; Erol K Farmaco; 1999 Jun; 54(6):359-63. PubMed ID: 10576776 [TBL] [Abstract][Full Text] [Related]
10. 4-difluoro-substituted phenl-5-oxohexahydroquinoline derivatives and their effects on calcium channels. Simşek R; Gündüz MG; Sirmagül B; Safak C; Erol K; Linden A Arzneimittelforschung; 2006; 56(7):529-34. PubMed ID: 16927535 [TBL] [Abstract][Full Text] [Related]
11. 3-Acetyl-4-aryl-5-oxo-2,7,7-trimethyl-1,4,5,6,7,8-hexahydro-quinoline derivatives and their calcium antagonistic activities. Safak C; Ozkanli F; Erol K; Aktan Y Arzneimittelforschung; 1995 Nov; 45(11):1154-6. PubMed ID: 8929229 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and calcium antagonistic activity of 2,6,6-trimethyl-3-carbomethoxy(ethoxy)-4-aryl-1,4,5,6,7,8-hexahydroquinoline derivatives. Simşek R; Ismailoğlu UB; Safak C; Sahin-Erdemli I Farmaco; 2000; 55(11-12):665-8. PubMed ID: 11204940 [TBL] [Abstract][Full Text] [Related]